New Developments in Triple-Negative Breast Cancer Therapies

(MedPage Today) --The recent virtual American Society of Clinical Oncology (ASCO) annual meeting featured several breast cancer clinical trials, including GeparNuevo, which looked at the addition of durvalumab (Imfinzi) to anthracycline- and...